Booth 18
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
Booth 3 & 4
As the manufacturer of Advantage™ I-125 and Pd-103 seeds for over 20 years, IsoAid specializes in providing Brachytherapy seeds for the treatment of prostate, ocular and breast cancer, as well as for diagnostic localization purposes. We are a full-service company you can always rely on, making seeds at the activity you request, custom-loading and delivering them faster than anyone in the industry. Through our exclusive partnership with Eye Physics we give you access to cutting edge eye plaques and planning services, which deliver many clinical advantages to you and your patients. High-activity seeds are custom-loaded using COMS or Eye Physics plaques. Our innovate Secure Strand™ cuts down significantly on seed migration for prostate patients and is now being used for RSL with great success. Our team of experts is dedicated to helping with every aspect of your program and is happy to serve as a complete resource for you. IsoAid is invested in the future of Brachytherapy and we look forward to introducing you to some exciting new advances very soon.
Booth 5 & 6
Theragenics partners with physicians, healthcare providers, and medical associations to deliver effective cancer treatments to patients worldwide. Our brachytherapy portfolio includes the industry leading TheraSeed® Palladium-103 seed and AgX100® Iodine-125 seed, both sourced and manufactured within North America.
As a brachytherapy pioneer, Theragenics is known for delivering quality seeds, strands, pre-loaded needles, and carriers, all with personalized service. And because we’re committed to providing effective, minimally invasive treatment options with minimal side effects, we continue to invest in this space. For more information, please visit www.theragenics.com.
Booth 17
At Varian, a Siemens Healthineers company, we are working to create a world without fear of cancer. For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning, and data analytics to address and enhance the entire cancer care journey and expand access to care. To learn more about our solutions, go to http://www.varian.com.
Booth 22
For more than 40 years, Best Medical has served the medical community with the highest quality products and unparalleled customer service. Our brachytherapy (Iodine/Pd/Iridium/Gold) seeds, gold fiducial markers, supplies, accessories (needles, templates, applicators, catheters) and other products exemplify our commitment to uncompromised quality and safety. Best Medical International now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions. Our aim is to be the one partner that clinicians turn to for all their radiotherapy and oncology product and service requirements.
Booth 10
BioProtect is a technology platform company that provides innovative biodegradable spacing solutions. Currently commercially available is our BioProtect Balloon, which addresses radiation-induced rectal toxicity in prostate cancer patients. Our vision is to become a world leader in spacing technology and to protect healthy organs during radiation therapy treatment. BioProtect’s first application, the BioProtect Balloon Implant System, is commercially available in Europe and in the US.
.png){kind=logo}
Booth 7 & 8
CQ Medical is the global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. Our company has more than 80 years of combined experience bringing to market advanced hardware and consumables for patient immobilization and positioning and patient care products, including the Symphony® Patient Transport System that revolutionized the movement of patients between procedural, imaging, and treatment modalities for HDR brachytherapy workflows.
Tabletop 8
Description: GammaTile is FDA-cleared to treat operable brain tumors including newly diagnosed malignant and recurrent brain tumors. Implanted during brain tumor resection, GammaTile uses collagen tiles that are embedded with radiation sources providing an immediate, dose-intense treatment to eliminate residual tumor cells. This "one and done" procedure allows patients to receive radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy.
Booth 15 & 16
Barrigel, by Teleflex, is an injectable biodegradable rectal spacer that separates the prostate from the rectum to protect it during radiation therapy treatment for prostate cancer. A groundbreaking spacing technology, it is the first and only hyaluronic acid, visually-guided, sculptable spacer for customizable coverage. Learn more at barrigel.com.
Booth 13
Digitizing the 'Last Mile' in Radiation Therapy. 3D printed, patient-specific accessories to improve clinical precision and patient experience.
Booth 12
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com
Booth 19
BEBIG Medical GmbH is a global provider of radiation therapy products dedicated to cancer treatment with 40 years experience in the field and a track record of proven clinical outcomes through robust and innovative technology.
Specializing in the research and development, manufacturing, and worldwide distribution of radiation therapy medical devices, BEBIG Medical provides comprehensive product portfolio with linear accelerator, high-dose-rate brachytherapy, X-ray therapy products, and intraoperative radiation therapy devices.
BEBIG Medical boasts a substantial presence with over 700 active installation bases across more than 80 countries and regions, facilitated by a network of over 70 global distributors. With strategically positioned offices and a team of seasoned professionals in Europe, United States, and Asia, the company aims to deliver affordable healthcare solutions to everyone in the world.
For more information, please visit www.bebigmedical.com
Booth 2
The next generation of BK Medical has arrived! As GE HealthCare’s Surgical Visualization and Guidance ultrasound solution, we are continuing the company’s mission to connect cancer and care with our product portfolio. In combination with a variety of specialized transducers, our systems provide high resolution imaging for needle guidance and source placement, with the option to include fullyintegrated digital planning software. Explore the bkPortfolio.
Booth 14
CivaTech Oncology is dedicated to localized radiation, precision therapy, without the beam. The implantable CivaSheet ® features a polymer encapsulated Pd-103 source, the only LDR brachytherapy device customizable to a specific patient and unidirectional to shield healthy tissue- the Gold side is Cold! CivaString ® is also a Pd-103 source with a unique linear radioactive distribution providing refinement on traditional prostate seeds- all polymer, no titanium, less needles, less swelling, less symptoms. And CivaDerm ® is FDA cleared surface radiation therapy, a one time, 5-day bandage that delivers a curative dose to treat non melanoma skin cancers.
Booth 9
Keeping up with challenging plans, documentation, and urgent demands can distract from treating patients. This is why our founders, a team of clinical physicists, came together to develop a better way. Our suite of automation tools enables thousands of the hardest-working cancer clinics across the world to do more in less time. Our software solutions utilise intelligent automation to bring efficiency and accuracy to the treatment planning process—automating contouring, treatment planning, plan evaluation, secondary calculations, weekly physics checks, and more. Experience increased quality, safety, and efficiency in treatment planning with Radformation.
Products & Services
Booth 1
MIM Software Inc. offers a powerful combination of solutions:
MIM Symphony® comprises a complete pathway solution for prostate cancer. Visit https://www.mimsoftware.com/ for prostate fusion and brachytherapy products.
Booth 11
Orfit brings high precision and comfort to the positioning and immobilization of cancer patients in Radiation Oncology. The Zephyr HDR system utilizes patented hover technology to allow patient transfer from procedure to imaging to treatment while maintaining patient positioning and minimizing the risk of needle/applicator displacement. Visit www.orfit.com for more information.
Tabletop 14
Alpha Tau Medical develops and commercialize the Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), an innovative technology that enables the highly potent and uniquely conformal alpha-irradiation of solid tumors. The treatment is delivered by intratumoral insertion of radionuclide Radium-224, which leads to the release and diffusion of daughter radioisotopes that emit alpha particles. These alpha particles have the capacity to destroy solid tumors. Since the alpha-emitting atoms diffuse only a short distance in tissue, Alpha DaRT mainly damages the tumor, while sparing the healthy tissue around it.
Tabletop 7
Boston Scientific partners with physicians to continually advance the quality of patient care with innovative solutions so you can choose the right technology and the right technique for every patient – without compromise. Visit our booth and speak with a representative to learn more.
Tabletop 6
C4 Imaging pioneers cutting-edge MRI-positive signal markers, revolutionizing precision treatment planning and cancer therapy. Their flagship innovation, NOVA, stands alone as the premier MRI-positive signal fiducial marker, delivering precise daily treatment alignment, reduced dose perturbation, and pinpoint tumor localization for focal therapy.
Tabletop 11
CIVCO Medical Solutions offers a robust portfolio of equipment and devices for the diagnosis and treatment of prostate cancer. AccuCARE™ steppers and stabilizers may be used in brachytherapy, fiducial marker placement, template-guided biopsies, and cryotherapy procedures. CIVCO recently launched its TP Pivot Pro™ needle guide, which enables a freehand and minimally invasive approach to ultrasound-guided transperineal prostate biopsies. Visit CIVCO.com to learn more.
Tabletop 5
Gold Anchor MR+ is a fiducial marker with proven clinical benefits: our industry leading thin needles enable safe implantation in almost any inner organ; the unique folding marker design allows for no lead time between implantation and CT/MRI; the markers can be tracked for intrafraction motion management; and the patented marker material (1.5% pure iron in an alloy with gold) provides enhanced MRI visibility especially on T2-weighted images.
Tabletop 12
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.
Tabletop 13
Increase confidence in your patient treatment plan QA process while gaining efficiency with RadCalc intelligent automation QA workflows. Our Brachytherapy module computes an independent 3D dose map to QA against your treatment planning system. With DVH analysis and Gamma evaluation tools and point dose reporting. RadCalc, a product of the LAP Group, is your gold standard in HDR, LDR and Permanent Implant patient QA. Visit us at RadCalc.com
Tabletop 9
RC Billing is the largest privately held oncology billing company in the US and the provider of choice for over 350 of the nation’s top medical, radiation, and surgical oncology practices. With over 20 years of experience in both the business and clinical side of oncology practices, RC Billing understands the pressures that today’s oncology providers are under.
Our sister company, RCCS, is the premier provider of healthcare business solutions. We offer revenue cycle management, coding strategies, strategic consulting, documentation and compliance reviews, custom services, and educational resources across most specialties. Healthcare business solutions. It's in our DNA.
Tabletop 4
Veracyte offers the Decipher Prostate Genomic Classifier to help with treatment planning for prostate cancer. Decipher Prostate provides prognostic information to help assess each patient’s individual risk and has been validated in over 80 studies as the most accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.
